1,435 press releases in English indexed under industrial.
ABU DHABI, United Arab Emirates, Aug. 20, 2026 -- Ittihad International Investment LLC ("Ittihad" or "the Group"), a leading diversified industrial conglomerate in the UAE, today announced its financial results for the six months ended June 30, 2026.
Delray Beach, FL , Aug. 20, 2026 -- MarketsandMarkets™ projects the electric construction equipment market is projected to grow from USD 3.81 billion in 2026 and to reach USD 13.81 billion by 2033, at a Compound Annual Growth Rate (CAGR) of 20.2% during the forecast period. The market for electric construction equipment is rapidly growing, driven by new EU targets that require a 55% reduction in greenhouse gas emissions by 2030. Additionally, major cities like Oslo aim for zero-emission construction sites by the same year. Recent noise regulations in Europe and North America are also influencing this shift; for example, the EU's Outdoor Noise Directive restricts construction equipment noise to under 80 dB(A) for many machine classes.
SUGAR LAND, Texas, August 20, 2026--For decades, the defining challenge of business intelligence was access. Companies needed better ways to collect information, organize it, and turn enormous datasets into something useful. Artificial intelligence (AI) is changing that equation by making it possible to move from a question to an answer almost immediately.
Vancouver, British Columbia--(August 20, 2026) - SAGA Metals Corp. (TSXV: SAGA) (OTCQB: SAGMF) (FSE: 20H) ("SAGA" or the "Company"), a North American exploration company focused on critical mineral discoveries, is pleased to announce that it has been approved as a member of the Defense Industrial Base Consortium ("DIBC"), a U.S. Department of Defense-supported initiative managed by Advanced Technology International ("ATI").Membership in the DIBC strengthens SAGA's position...
HONG KONG, August 20, 2026 - Recently, Guoquan Food (02517) announced its interim results for the six months ended 30 June 2026. The Group recorded revenue of RMB3,947 million, representing an increase of 21.8% year-on-year. Gross profit was RMB849 million, up 18.3% year-on-year, and net profit was RMB213 million, up 12.1% year-on-year. Core operating profit (non-IFRS measure) amounted to RMB225 million, up 18.3% year-on-year, representing a core operating profit margin of 5.7%. Existing Franchised Stores Sales up 7.4%; Large-Store Remodelling Reshapes Per-Store Value When assessing the operational quality of a chain retail enterprise, sales of products to existing franchised stores are a more meaningful metric than new store opening numbers. As of 30 June, the Group had a total of 12,198 stores, representing a net increase of 1,798 stores. During the period, 365 stores were closed, with a store closure rate of below 3%. Revenue from existing franchised stores amounted to RMB2,581 million, representing a year-on-year increase of 7.4%. Excluding the impact of new store ramp-up, this indicates that the existing franchised store network still possesses organic growth momentum. Behind the growth of existing franchised stores, large-store remodelling served as the primary driver. In the first half of the year, 684 stores completed the upgrade to the large-store model. This upgrade is not simply about expanding floor space, but rather about using larger physical space to accommodate a wider range of categories and extended operating hours – expanding consumption scenarios from hotpot and barbecue to cover all daily meal occasions, and upgrading stores from mere ingredient sales points into comprehensive community family dining entry points. Penetration into lower-tier markets progressed simultaneously. The number of stores in township markets reached 3,377. By precisely targeting these markets with high-cost-performance bulk-sale items and large-pack family packs, the “one store per town” strategy taps into the vast hinterland of approximately 38,000 townships nationwide, with penetration potential far from being exhausted. Farm Business Grows Over Sixfold, New Growth Engine Takes Shape Online and membership data also recorded rapid growth. Registered members reached approximately 82 million, representing a year-on-year increase of 63.0%. Member consumption accounted for 73.2% of total sales, up 12 percentage points year-on-year, indicating that the revenue structure is increasingly concentrated among highly loyal customer groups. The Douyin channel saw significant growth: platform exposure exceeded 6.97 billion views, up 117.8% year-on-year; store GMV on Douyin reached RMB910 million, up 97.2%, initially forming a closed loop between online traffic and offline conversion. Guoquan Farm was the fastest-growing business segment during the period. Its omni-channel paid GMV reached RMB240 million, up over 600% year-on-year, and it brought in over 1.92 million new members for the stores. This model does not set up an independent e-commerce platform; instead, it leverages the existing store network as front-end warehouses and pickup points, while online content seeding and traceability livestreams drive traffic, forming a closed loop of “direct sourcing – content seeding – online ordering – in-store pickup”, which theoretically reduces marginal costs. Among best-selling products, the Golden Pillow Durian Pulp attracted a total of 1.559 million buyers, with a repurchase rate of 22.06%, and also boosted sales of related categories such as durian mille-crêpe cakes, Beihai cooked salted duck eggs, and crispy ice cream. In August, the “Grassland Sheep Traceability” livestream achieved over 8.09 million total exposures within three hours, with a peak concurrent viewership of 173,000. The Farm model completely removes the physical constraints of store floor space and freezer capacity from Guoquan’s category boundaries – the “infinite shelf” combined with a 10,000-store fulfilment network represents a critical leap forward in its transformation from a hotpot ingredient retailer to a full-category platform for home dining. Institutionalised Return Mechanisms; Hong Kong Flagship Store Launched The Board proposed the payment of an interim dividend of RMB0.0503 per ordinary share (tax inclusive), totalling approximately RMB128 million. During the period, the Group repurchased a total of 82,201,200 H shares on the Stock Exchange at an aggregate consideration of approximately HK$192 million. The dividend together with the share buybacks amounted to approximately RMB296 million, equivalent to 139.9% of the profit attributable to owners of the parent for the period (RMB211 million). The shareholder return ratio increased from 5.6% in 2024 and 2025 to 7.1%. In addition to the amount, the Board also approved the 2026 H-Share Equity Incentive Plan, which adopts core operating profit as the performance indicator. The reference target values for the years 2026 to 2030 are set to gradually increase from no less than RMB600 million to no less than RMB1.2 billion. By anchoring the assessment to profit rather than revenue or store count, the plan helps guide management to focus on profitability, better aligning management’s interests with those of shareholders. The high dividend payout provides immediate returns, while the equity incentive focuses on long-term growth. The Hong Kong flagship store opened on 18 August, serving as the first stop for the brand’s overseas expansion. Its positioning is not rapid replication, but rather validating the large-store model in high-tier cities and localised supply chain capabilities. According to publicly available data, the Greater Bay Area, with a population of 87 million and an economic aggregate of RMB15 trillion, coupled with the logistics efficiency of the “one-hour living circle”, provides ample room for subsequent regional deepening. Integrated Manufacturing-Retail Closed Loop; Synergies Gradually Unfolding Linking these strategies together is the “manufacturing-retail integration” capability that Guoquan has built over the years. On the front-end “retail” ecosystem – community stores, township stores, large stores, camping stores, stir-fry stores, flash delivery, and Farm – it reaches consumers, understands scenarios, and accumulates member data. On the back-end “manufacturing” ecosystem – seven ingredient production facilities covering core categories such as seasonings, beef, surimi, and aquatic products, with a “single product, single factory” strategy complemented by digitalised central warehouses – it converts front-end demand into scaled product supply. During the period, external sales from the industrial end increased by 20.7% year-on-year, reflecting the potential for the supply chain capability to be externally deployed. The Danzhou Industrial Park in Hainan was topped out, Heyi Meat’s Phase II commenced production, and the Daixiaji Zhangzhou factory was contracted, indicating that the production capacity landscape continues to expand. Looking ahead to the second half of 2026, with the continued replication of the large-store model, the regular operation of the Farm traceability IP, and the gradual accumulation of operating data from the Hong Kong flagship store, Guoquan is expected to gain clearer market recognition of its positioning as a “home dining infrastructure platform”. From a 10,000-store scale to an ecosystem platform, Guoquan’s strategic transformation is entering a substantive realisation phase.
NANJING, CHINA, August 20, 2026 - Aug 19, HELP Therapeutics today announced the Nature Medicine publication of 12-month results from the HEAL-CHF clinical trial evaluating HiCM-188, an investigational allogeneic human iPSC-derived cardiomyocyte (hiPSC-CM) therapy for the treatment of severe ischemic heart failure. The randomized controlled trial enrolled 20 patients, assigned 1:1 to receive either coronary artery bypass grafting (CABG) alone or CABG combined with transepicardial HiCM-188 injection. The study achieved both pre-specified primary safety endpoints, demonstrating no treatment-related tumor formation through 12 months and no sustained ventricular tachycardia through 6 months. At 12 months, 90% of patients receiving transepicardial HiCM-188 injection combined with (CABG improved to NYHA Class II, versus 60% of patients in the CABG-only group.. "HEAL-CHF provides the first clinical evidence that delivering HiCM-188 intraoperatively during CABG may combine the benefits of revascularization with myocardial regeneration," said Professor Dongjin Wang, Lead Author and Director of the Department of Cardiothoracic Surgery at Nanjing Drum Tower Hospital. "Over 12 months, we observed no serious cell-related adverse events alongside encouraging signs of reverse cardiac remodeling. Given the substantial global burden of heart failure and the persistent shortage of donor hearts, regenerative approaches like HiCM-188 have the potential to fill a critical unmet need for patients living with end-stage disease." "The publication of the HEAL-CHF study in Nature Medicine reflects years of dedication to advancing breakthrough stem cell technologies into clinically validated therapies," said Dr. Eugene Jiaxian Wang, Chief Executive Officer of HELP Therapeutics. "With our pivotal Phase III trial now enrolling patients in China and our Phase I program initiating in the U.S., we are eager to maintain this momentum as we work toward bringing a new regenerative medicine breakthrough to heart failure patients worldwide." About HiCM-188 HiCM-188 is an investigational allogeneic human induced pluripotent stem cell-derived cardiomyocyte (hiPSC-CM) therapy designed as a standardized, off-the-shelf product for scalable manufacturing and distribution. HiCM-188 is the first iPSC-derived cardiomyocyte therapy worldwide to obtain Investigational New Drug (IND) clearances from both the U.S. FDA and China's NMPA. It is currently being evaluated in a multicenter Phase III trial in China led by TEDA International Cardiovascular Hospital, and a Phase I trial in the United States at the Texas Heart Institute. About HELP Therapeutics Founded in 2016, HELP Therapeutics is a global clinical-stage biopharmaceutical company developing iPSC-based cell therapies for cardiovascular and other degenerative diseases. The company leverages proprietary off-the-shelf cell therapy platforms and national iPSC bank infrastructure to ensure scalable clinical and commercial delivery. HELP Therapeutics has established a commercialization partnership with China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SZSE: 000999) to build out distribution infrastructure in China. For more information, please visit https://en.helptherapeutics.com. Disclosure Notice The information contained in this release is as of August 19, 2026. HiCM-188 is an investigational product and has not been approved for commercial use by the U.S. Food and Drug Administration, China National Medical Products Administration, or any other regulatory authority. This release contains forward-looking statements regarding HiCM-188, including potential clinical benefits and regulatory development timelines, which involve substantial risks and uncertainties that could cause actual results to differ materially. References & Publication Details 1.Journal: Nature Medicine (2026) DOI: 0.1038/s41591-026-04605-1 2.Clinical Trial Registry: ClinicalTrials.gov (NCT03763136) 3.Ethics Approval: Nanjing Drum Tower Hospital IRB (No. SC202000102); National Health Commission of China (MR-32-21-014649)
HONG KONG, August 20, 2026 - 1. Revenue: Net Interest Income Drives Growth; Fee-Income Volatility Mirrors Broader Industry Trends Bank of Chongqing's headline revenue figures provide a useful starting point. In 2025, the bank reported revenue of RMB 15.113 billion, up 10.48% year on year, while net profit attributable to shareholders rose 10.49% to RMB 5.654 billion. The momentum carried into the first quarter of 2026. Revenue increased 11.57% to RMB 3.996 billion and net profit rose 11.22% to RMB 1.898 billion, marking another quarter of double-digit growth in both metrics. Preliminary results for the first half of 2026 showed revenue of RMB 8.486 billion, up 10.80% year on year; profit before tax of RMB 4.081 billion, up 7.82%; and net profit attributable to shareholders of RMB 3.518 billion, up 10.28%. This marked a fourth consecutive quarter of double-digit growth in both revenue and attributable net profit, making Bank of Chongqing the only bank among the 42 listed on China's A-share market to do so. A closer look at the revenue mix shows that net interest income has been the principal growth engine. It reached RMB 12.459 billion in 2025, an increase of 22.44%. The momentum remained firm in 2026, with first-quarter net interest income rising 12.83% to RMB 3.548 billion, pointing to another solid first-half performance. As a locally rooted city commercial bank, Bank of Chongqing has played an active role in supporting the Chengdu-Chongqing Economic Circle and the New International Land-Sea Trade Corridor. Growth backed by strong demand from the real economy is more sustainable and gives the bank a defensible revenue base in an increasingly competitive market. Fee and commission income tells a different story. Banks' fee businesses have entered a period of deep adjustment amid tighter enforcement of rules requiring reported bancassurance commission rates to match actual payments, lower mutual-fund distribution fees, and volatility in wealth-management markets. Sharper swings in wealth-management markets produced a marked divergence in fee income among listed city commercial banks in 2025. Against the backdrop of interest-rate liberalization, while a handful of institutions continued to grow on the back of the sector's winner-takes-more dynamics, the industry remained broadly under pressure, with several listed city commercial banks recording declines of around 30% in net fee and commission income. Bank of Chongqing held up relatively well: the decline in its fee income narrowed in 2026, with early signs of stabilization and recovery. The bank has also made headway in improving the quality of its fee income. In 2025, it ranked first in Chongqing by non-financial corporate bond underwriting volume, market share, and number of issues. It also led locally incorporated financial institutions across western China. In trade finance, cross-border renminbi settlement volume increased by more than 120% year on year. These higher-quality fee income streams, underpinned by stronger service capabilities, are gradually displacing traditional conduit business and emerging as a new growth driver. Net interest margin, or NIM, rose to 1.39% in 2025 from 1.35% in 2024, an increase of 4 basis points. A breakdown of asset yields and funding costs shows what drove the improvement: Although the average yield on loans fell by 12 basis points, the average cost of deposits declined by 37 basis points. The larger reduction in funding costs offset downward pressure on asset yields, enabling the bank to deliver a stronger improvement in NIM than the industry average and highlighting more effective management of deposit pricing. Total assets reached RMB 1.034 trillion at the end of 2025, up 20.67%, taking the bank above the RMB 1 trillion threshold. Expansion continued in 2026: assets rose to RMB 1.108 trillion at the end of March, up 7.20% from year-end, and to RMB 1.109 trillion at the end of June, up 7.27% from end-2025. Market observers see the bank's growth potential at its new scale as evidence that its “Five Highs” operating strategy, centered on ambitious goals, strategic transformation, efficient operations, quality service, and high-quality growth, is gaining traction. Through greater efficiency and higher-value services, Bank of Chongqing has achieved a step-change in scale and built a more differentiated competitive position as it moves toward the ranks of leading listed commercial banks. As a locally rooted financial institution, Bank of Chongqing has anchored its growth in China's Western Development strategy and achieved a step-change in scale as it grew in tandem with the regional economy. Outstanding corporate loans rose 30.95% year on year at the end of 2025. Backed by coordinated execution across the organization, credit was directed to national priorities including the Chengdu-Chongqing Economic Circle and the New International Land-Sea Trade Corridor, as well as Chongqing's '33618' modern manufacturing cluster system. The annual report showed a 60% increase in outstanding loans to technology-based enterprises and 40% growth in green lending. Manufacturing loans posted their largest absolute increase and fastest growth in five years. Outstanding financing in support of the New International Land-Sea Trade Corridor exceeded RMB 55 billion. This lending not only supports the real economy but also embeds the bank more deeply in customers' transaction flows, helping it attract substantial low-cost demand deposits as its balance sheet expands. 2. Risk: Broad-Based Improvement in Forward-Looking Indicators Reinforces Asset Quality Bank of Chongqing has put its belief that 'risk management creates value' into practice by upgrading its risk controls and steadily reducing risk exposure. At the end of 2025, the non-performing loan ratio fell by 11 basis points year on year to 1.14%. More importantly for investors, forward-looking asset-quality indicators improved in tandem: the special-mention loan ratio and overdue loan ratio declined by 70 basis points and 37 basis points from the start of the year to 1.94% and 1.36%, respectively. Asset quality improved further in the first quarter of 2026. At the end of March, the non-performing loan ratio fell by another 2 basis points to 1.12%, while the provision coverage ratio rose by 1.02 percentage points from year-end to 246.60%. The continued improvement in these forward-looking indicators, together with steadily rising provision coverage, reduces the risk of potential problem loans migrating into the non-performing category, strengthens the margin of safety, and highlights the bank's capacity to absorb credit risk. 3. Institutional Views: Capital Replenishment Potential and the Case for a Valuation Re-rating At the end of 2025, the bank's core Tier 1 capital adequacy ratio stood at 8.53%. Rapid asset growth has consumed some capital, but the bank's RMB 13 billion convertible bond is now in its conversion period. Chongqing Expressway Group's decision to convert its holdings into shares may be only the beginning. By the end of March 2026, the bank's core Tier 1 and total capital adequacy ratios had risen to 8.67% and 12.57%, respectively. Institutional estimates suggest that full conversion of the remaining bonds could materially strengthen capital and create room for continued balance-sheet expansion during China's 15th Five-Year Plan period. After Bank of Chongqing released its annual and first-quarter reports, the market response was broadly positive. Analysts at CITIC Securities, China Merchants Securities, Zhongtai Securities, Guotai Haitong Securities, China Galaxy Securities, and Zheshang Securities published a series of follow-up notes, with ratings ranging from Buy and Overweight to Recommend and Outperform. The common thread across the reports was that the bank's move beyond RMB 1 trillion in assets was not simply a story of scale; it was also accompanied by tangible progress in lowering funding costs and improving asset quality. 4. Conclusion: A Clear Case for a Return to a More Reasonable Valuation Taken together, Bank of Chongqing's performance in 2025 and the first half of 2026 points to several positive shifts: assets have crossed RMB 1 trillion, revenue and profit growth have returned to double digits, NIM has bottomed and begun to recover, and risk indicators continue to decline. These stronger fundamentals could increasingly feed through to the bank's market valuation. According to a June 9 report by BOCOM International, the banking sector was trading at between 0.5 and 0.8 times book value, near the bottom of its valuation range. That has sharpened investor focus on listed banks' share-price performance and market-capitalization management practices. Changjiang Securities argues that a turning point in fund flows into bank stocks is already in place. Broad-based index funds tracking the CSI 300 recorded net outflows of nearly RMB 1 trillion in the first half of 2026, while active mutual funds' exposure to banks fell to a record low. The brokerage believes the impact of those reductions has now been fully absorbed, and that bank valuations will enter a slow, gradual recovery from the second half of 2026. With sector NIMs stabilizing and earnings expectations improving, high-quality regional city commercial banks are drawing renewed institutional interest. As confidence in Bank of Chongqing's re-rating case grows, a higher weighting in institutional portfolios, together with the stock's high dividend yield and low valuation, could help the shares move decisively out of undervalued territory and toward a more reasonable valuation.
KAWASAKI, Japan, August 20, 2026--Toshiba launches a compact 80V eFuse IC for 48V power line protection in industrial equipment, featuring multiple protection functions.
Kaspersky's purpose-built OT security and unified IT/OT approach demonstrates strong customer value, product innovation, and operational resilience across critical industrial environments. SAN ANTONIO, Aug. 19, 2026 -- Frost & Sullivan is pleased to announce that Kaspersky...
FREMONT, Calif., August 19, 2026--Hyve Solutions Corporation, a US-based design and manufacturing partner for compute, storage, and networking systems in AI, cloud, and digital infrastructure, and a wholly owned subsidiary of TD SYNNEX Corporation (NYSE: SNX), today announced two new advanced manufacturing campuses in Nevada, one in Reno and one in North Las Vegas, to support increased customer demand.
A phased roadmap with a major international polyester materials producer begins with a contemplated commercial facility in the tens of millions of pounds annually and creates a conditional pathway toward potential multi-facility scale measured in billions. A phased roadmap with a major international polyester materials producer begins with a contemplated commercial facility in the tens of millions of pounds annually and creates a conditional pathway toward potential multi-facility scale measured in billions.
FALLS CHURCH, Va., Aug. 19, 2026 -- The board of directors of Northrop Grumman Corporation (NYSE: NOC) declared a quarterly dividend of $2.47 per share on Northrop Grumman common stock, payable September 16, 2026, to shareholders of record as of the close of business August 31, 2026. Northrop Grumman continues to execute a disciplined capital allocation strategy that prioritizes investments in the manufacturing capabilities and capacity needed to deliver differentiating technologies quickly for our customers.